Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
August 4, 2015
Patent Application Number
14348138
Date Filed
September 28, 2012
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to novel macrocylic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of LRRK2 (Leucine-Rich Repeat Kinase 2). Moreover, the present invention provides processes for the preparation of the disclosed compounds, as well as methods of using them, for instance as a medicine or diagnostic agent, in particular for the treatment and/or diagnosis of diseases characterized by LRRK2 kinase activity such as neurological disorders including Parkinson's disease and Alzheimer's disease.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
